OECD: Boosting biotechnology innovation through agile regulation and finance instruments
REPORT
France, November 2025 - Biotechnology—the use and modification of living organisms and derived elements to produce knowledge and products—has become a cornerstone of modern innovation. Spanning health, agriculture, and manufacturing, biotech applications promise to be powerful tools to tackle global challenges from pandemics to food security to environmental crises. As a result, policymakers worldwide are seeking to strengthen the biotechnology capabilities of their economies and participation in the global bioeconomy.
Within this landscape, biosolutions—biotechnology innovations beyond biomedical applications —are emerging as a major opportunity. According to the European Commission, biosolutions could save up to 2.5 billion tons of CO2 equivalent per year by 2030 by substituting fossil-based products with other environmental and technical improvements. They can bring other benefits like creating new markets and jobs in rural and coastal regions where biological resources are produced.
This brief explores the biotechnology innovation landscapes in the European Union and the United States to identify shared challenges and lessons that can accelerate innovation on both sides of the Atlantic.
Source: OECD.
